Behavioral task
behavioral1
Sample
12abd060a52a4b3a09fbb1cd7d688e45cf7c036a3fd98592aa74b92be28974af.pdf
Resource
win7-20240221-en
Behavioral task
behavioral2
Sample
12abd060a52a4b3a09fbb1cd7d688e45cf7c036a3fd98592aa74b92be28974af.pdf
Resource
win10v2004-20240226-en
General
-
Target
12abd060a52a4b3a09fbb1cd7d688e45cf7c036a3fd98592aa74b92be28974af
-
Size
723KB
-
MD5
9c57aefce73c39a91d6cc8025cce5ae3
-
SHA1
5c7601d2a41ac5def3728534c11cf29c749b5869
-
SHA256
12abd060a52a4b3a09fbb1cd7d688e45cf7c036a3fd98592aa74b92be28974af
-
SHA512
45f909988f005aadfae0a87c384cf4021f45c684bff8e857c5570ed8b97511d23b2a33511e26d8b44e8c72d77a75f9031f14dd625587ae9609b79a326aa1af6e
-
SSDEEP
12288:gSyIWv0w+DeE33tVyveFhzEHcMYpVDL9nt+67jP7Ds2+i9Bdm6G:gSyZvt+D/ntVyv6aEVDxnt/n7DT+ipmt
Malware Config
Signatures
Files
-
12abd060a52a4b3a09fbb1cd7d688e45cf7c036a3fd98592aa74b92be28974af.pdf
-
https://swachhindia.ndtv.com/indias-covid-vaccination-programme-explained-who-will-get-it-first-what-is-the-process-and-other-things-you-need-to-know-54989/
-
https://www.prnewswire.com/news-releases/codagenix-and-serum-institute-of-india-announce-commencement-of-first-in-human-trial-of-covi-vac-a-single-dose-intranasal-live-attenuated-vaccine-for-covid-19-301191756.html
-
https://www.ndtv.com/coronavirus/fullcoverage
-
https://www.bharatbiotech.com/covaxin.html
-
https://www.bbc.com/news/world-asia-india-55748124
-
https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html
-
https://doi.org/10.3390/vaccines9020081
-
https://www.mobihealthnews.com/news/emea/intranasal-covid-19-vaccines-developed-additional-protection
-
https://pipelinereview.com/index.php/2020041774358/Vaccines/Moderna-Announces-Award-from-U.S.-Government-Agency-BARDA-for-up-to-$483-Million-to-Accelerate-Development-of-mRNA-Vaccine-mRNA-1273-Against-Novel-Coronavirus.html
-
https://clinicaltrials.gov/ct2/show/study/NCT04450004
-
https://clinicaltrials.gov/ct2/show/NCT04636697
-
https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3#:~:text=(Nasdaq%3A%20NVAX)%2C%20a,the%20United%20Kingdom%20(%20UK%20)
-
https://doi.org/10.1172/jci.insight.140329
-
https://doi.org/10.1086/520143
-
https://doi.org/10.1101/2020.12.09.20245175
-
https://health.economictimes.indiatimes.com/news/pharma/serum-institute-seeks-emergency-use-authorisation-for-oxford-covid-19-vaccine-covishield-in-india/79600227
-
https://doi.org/10.1038/s41565-020-0737-y
-
https://doi.org/10.1016/j.eclinm.2020.100689
-
https://dx.doi.org/10.3390%2Fvaccines2030624
-
https://github.com/owid/covid-19-data/blob/master/public/data/vaccinations/country_data/India.csv
-
https://doi.org/10.1016/j.vaccine.2009.01.125
-
https://covid19.who.int/
-
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
-
https://apps.who.int/iris/handle/10665/338096
-
https://doi.org/10.1016/S1473-3099(20)30987-7
-
https://doi.org/10.1016/S1473-3099(20)30843-4
-
https://doi.org/10.52253/vjta.2021.v02i01.04
-
http://creativecommons.org/licenses/by-sa/4.0/
-
http://gmail.com
-
https://www.ndtv.com
-
https://www.cdc.gov
-
https://www.mobihealthnews.com/news/emea/
-
https://pipelinereview.com
-
https://clinicaltrials.gov/ct2/
-
https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3#:~:
-
http://economictimes.indiatimes.com/news/pharma/serum-institute-seeks-emergency-use-authorisation-for-oxford-covid-19-vaccine-covishield-in-india/79600227
-
https://covid19.who.int
-
https://www.who.int
-
https://doi.org/10.1016/S1473-3099
- Show all
-